Powered by lexis nexis

GeNeuro Publishes the English Version of Its 2016 Reference Document

May 02, 2017 - Business Wire

Regulatory News:

GeNeuro (Paris:GNRO) (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company developing new treatments for autoimmune diseases, including multiple sclerosis, publishes the English version of its 2016 Reference Document, which has been filed on April28,2017,with the "Autorité des Marchés Financiers (AMF)".

This document is available to the public free of charge, as provided for in applicable legislation, and may be viewed and downloaded on the Company's w...